These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32180741)

  • 1. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders.
    Giacobbe J; Benoiton B; Zunszain P; Pariante CM; Borsini A
    Front Psychiatry; 2020; 11():122. PubMed ID: 32180741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation.
    Joffre C; Rey C; Layé S
    Front Pharmacol; 2019; 10():1022. PubMed ID: 31607902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
    Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders.
    Kim N; Shin HY
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.
    Moro K; Nagahashi M; Ramanathan R; Takabe K; Wakai T
    World J Clin Cases; 2016 Jul; 4(7):155-64. PubMed ID: 27458590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders.
    Ponce J; Ulu A; Hanson C; Cameron-Smith E; Bertoni J; Wuebker J; Fisher A; Siu KC; Marmelat V; Adamec J; Bhatti D
    Front Aging Neurosci; 2022; 14():780811. PubMed ID: 35250536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A; Amabile MI; Monti M; Muscaritoli M
    Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation.
    Farooqui AA
    Curr Med Chem; 2012; 19(4):532-43. PubMed ID: 22204329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.
    Beyer MP; Videla LA; Farías C; Valenzuela R
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
    Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
    J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
    Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell.
    Weylandt KH
    Eur J Pharmacol; 2016 Aug; 785():108-115. PubMed ID: 26546723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
    Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
    Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
    Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of diets rich in omega-3 and omega-6 in the development of cancer.
    Huerta-Yépez S; Tirado-Rodriguez AB; Hankinson O
    Bol Med Hosp Infant Mex; 2016; 73(6):446-456. PubMed ID: 29421289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
    Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.